Shares of Sysmex Corporation ADR (OTCMKTS:SSMXY - Get Free Report) saw unusually-high trading volume on Thursday . Approximately 346,829 shares changed hands during mid-day trading, an increase of 321% from the previous session's volume of 82,297 shares.The stock last traded at $16.79 and had previously closed at $16.68.
Sysmex Stock Performance
The company has a current ratio of 2.97, a quick ratio of 2.30 and a debt-to-equity ratio of 0.12. The company's 50 day moving average is $16.98 and its 200-day moving average is $18.01. The company has a market capitalization of $10.58 billion, a P/E ratio of 30.00 and a beta of 1.14.
Sysmex (OTCMKTS:SSMXY - Get Free Report) last issued its quarterly earnings results on Wednesday, May 14th. The company reported $0.12 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.16 by ($0.04). The business had revenue of $958.89 million during the quarter, compared to the consensus estimate of $991.22 million. Sysmex had a return on equity of 11.81% and a net margin of 10.56%. Equities analysts anticipate that Sysmex Corporation ADR will post 0.57 EPS for the current fiscal year.
About Sysmex
(
Get Free Report)
Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Sysmex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sysmex wasn't on the list.
While Sysmex currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
